Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
Br J Haematol. 2018 Nov;183(4):601-607. doi: 10.1111/bjh.15585. Epub 2018 Sep 14.
Br J Haematol. 2018.
PMID: 30596402
Free PMC article.
Clinical Trial.
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.
Green DJ, Bensinger WI, Holmberg LA, Gooley T, Till BG, Budde LE, Pagel JM, Frayo SL, Roden JE, Hedin L, Press OW, Gopal AK.
Green DJ, et al. Among authors: roden je.
Bone Marrow Transplant. 2016 Oct;51(10):1330-1336. doi: 10.1038/bmt.2016.123. Epub 2016 May 23.
Bone Marrow Transplant. 2016.
PMID: 27214069
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
Budde LE, Zhang MM, Shustov AR, Pagel JM, Gooley TA, Oliveira GR, Chen TL, Knudsen NL, Roden JE, Kammerer BE, Frayo SL, Warr TA, Boyd TE, Press OW, Gopal AK.
Budde LE, et al. Among authors: roden je.
Br J Haematol. 2013 Apr;161(2):183-91. doi: 10.1111/bjh.12230. Epub 2013 Jan 29.
Br J Haematol. 2013.
PMID: 23356514
Free PMC article.
Clinical Trial.
Item in Clipboard
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
Cowan AJ, Stevenson PA, Gooley TA, Frayo SL, Oliveira GR, Smith SD, Green DJ, Roden JE, Pagel JM, Wood BL, Press OW, Gopal AK.
Cowan AJ, et al. Among authors: roden je.
Br J Haematol. 2017 Feb;176(4):583-590. doi: 10.1111/bjh.14451. Epub 2017 Jan 5.
Br J Haematol. 2017.
PMID: 28055107
Free PMC article.
Clinical Trial.
Item in Clipboard
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
Onishi M, Graf SA, Holmberg L, Behnia S, Shustov AR, Schiavo K, Philip M, Libby EN, Cassaday RD, Pagel JM, Roden JE, Maloney DG, Green DJ, Till BG, Press OW, Smith SD, Gopal AK.
Onishi M, et al. Among authors: roden je.
Hematol Oncol. 2015 Dec;33(4):187-91. doi: 10.1002/hon.2166. Epub 2014 Sep 18.
Hematol Oncol. 2015.
PMID: 25236531
Free PMC article.
Item in Clipboard
Looking Beyond Nursing Education Practice to Include Sustainable Health-Care Systems Processes.
Roden JE, Lewis T.
Roden JE, et al.
Creat Nurs. 2021 Nov 1;27(4):251-256. doi: 10.1891/cn-2021-0014.
Creat Nurs. 2021.
PMID: 34903628
Item in Clipboard
Cite
Cite